Literature DB >> 70292

Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development.

M Jondal, P Gunven.   

Abstract

Sera from patients with Burkitt's lymphoma (BL) were tested for antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus (EBV) determined antigens and for antibodies directed against various EBV-specific antigens. No correlation was found between EBV serology and ADCC in sera selected for high or low titres against the membrane antigens (MA) or in consecutive sera from three patients with isolated late tumour recurrences. Furthermore, no correlation was found between ADCC and tumour development.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 70292      PMCID： PMC1541044     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  19 in total

1.  Surface markers on human B and T lymphocytes. IV. Distribution of surface markers on resting and blast-transformed lymphocytes.

Authors:  M Jondal
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

2.  Immunological studies on a case of recurrent Burkitt's lymphoma during immune stimulant treatment.

Authors:  P Gunvén; G Klein; W Henle; G Henle; G Rocchi; J F Hewetson; A Guerra; P Clifford; S Singh; A Demissie; A Svedmyr
Journal:  Int J Cancer       Date:  1973-07-15       Impact factor: 7.396

3.  Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.

Authors:  G Miller; T Shope; H Lisco; D Stitt; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

4.  Blocking of direct membrane immunofluorescence in titration of membrane-reactive antibodies associated with Epstein-Barr virus.

Authors:  P Gunvén; G Klein
Journal:  J Natl Cancer Inst       Date:  1971-09       Impact factor: 13.506

5.  Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells.

Authors:  G Henle; W Henle; G Klein
Journal:  Int J Cancer       Date:  1971-09-15       Impact factor: 7.396

6.  Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients.

Authors:  P Gunvén; G Klein; G Henle; W Henle; P Clifford
Journal:  Nature       Date:  1970-12-12       Impact factor: 49.962

7.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

8.  Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups.

Authors:  G Henle; W Henle; P Clifford; V Diehl; G W Kafuko; B G Kirya; G Klein; R H Morrow; G M Munube; P Pike; P M Tukei; J L Ziegler
Journal:  J Natl Cancer Inst       Date:  1969-11       Impact factor: 13.506

9.  Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations.

Authors:  M Jondal; H Pross
Journal:  Int J Cancer       Date:  1975-04-15       Impact factor: 7.396

10.  Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus.

Authors:  G Klein; G Pearson; J S Nadkarni; J J Nadkarni; E Klein; G Henle; W Henle; P Clifford
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307
View more
  2 in total

1.  Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells.

Authors:  S Kumagai; A D Steinberg; I Green
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

2.  The Presence of Antibody-Dependent Cell Cytotoxicity-Mediating Antibodies in Kaposi Sarcoma-Associated Herpesvirus-Seropositive Individuals Does Not Correlate with Disease Pathogenesis or Progression.

Authors:  Lisa K Poppe; Charles Wood; John T West
Journal:  J Immunol       Date:  2020-09-30       Impact factor: 5.422
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.